| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 14, 2026 | Sell(S) | 2K | $9.50 | $21K | 270K |
| May 13, 2026 | Grant(A) | 5K | — | $0 | 272K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-226613) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Karyopharm Therapeutics Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.